AVBP — ARRIVENT BIOPHARMA INC
As of Q2 2026, 29 SEC-registered investment managers reported holding AVBP (ARRIVENT BIOPHARMA INC) in their latest 13F filings, with a combined reported value of $564.81M across 16.29M shares. That is +8.2% by share count (+1.24M shares) versus the previous quarter, while reported value moved +62.9%. Ownership is concentrated: the five largest holders account for 72.6% of reported value and the top ten for 89.2%.
Compared with the prior quarter, 2 opened new positions, 19 added to existing stakes, 6 trimmed, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
AVBP is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Hillhouse Capital (HHLR Advisors) history | Q2 2026 | 3.93M | $136.50M | 16.41% | Hold |
| BlackRock Inc history | Q2 2026 | 3.25M | $112.92M | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 2.78M | $96.54M | 0.01% | Reduce |
| Vanguard Group history | Q4 2025 | 1.87M | $37.61M | 0.00% | Reduce |
| Geode Capital Management history | Q2 2026 | 972.63K | $33.80M | 0.00% | Add |
| D. E. Shaw & Co history | Q2 2026 | 872.01K | $30.29M | 0.02% | Add |
| Goldman Sachs Group history | Q2 2026 | 853.72K | $29.66M | 0.00% | Hold |
| Point72 Asset Management history | Q2 2026 | 566.80K | $19.69M | 0.02% | Reduce |
| Millennium Management history | Q2 2026 | 438.66K | $15.24M | 0.01% | Add |
| UBS Group AG history | Q2 2026 | 438.59K | $15.24M | 0.00% | Reduce |
| Balyasny Asset Management history | Q2 2026 | 395.45K | $13.74M | 0.02% | Reduce |
| Northern Trust Corp history | Q2 2026 | 332.75K | $11.56M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 294.22K | $10.22M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 238.34K | $8.28M | 0.00% | Reduce |
| Morgan Stanley history | Q2 2026 | 189.91K | $6.60M | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 174.87K | $6.07M | 0.00% | Add |
| Franklin Resources history | Q3 2025 | 256.42K | $4.73M | 0.00% | New |
| BNY Mellon history | Q2 2026 | 103.93K | $3.61M | 0.00% | Add |
| Wellington Management Group history | Q2 2026 | 100.86K | $3.50M | 0.00% | Add |
| Farallon Capital Management history | Q1 2024 | 151.77K | $2.71M | 0.01% | New |
New Positions (Q2 2026)
- JPMorgan Chase & Co 65.69K sh · $2.26M
- Prudential Financial 6.21K sh · $215.91K
Fully Exited (vs previous quarter)
- Marshall Wace sold 35.16K sh · $811.26K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Hillhouse Capital (HHLR Advisors) | 3.93M | 4.48M | 4.48M | 4.48M | 4.48M | 4.48M | 4.48M | 3.93M | 3.93M | 3.93M |
| BlackRock Inc | — | — | 1.93M | 2.14M | 2.14M | 1.84M | 2.05M | 2.37M | 2.53M | 3.25M |
| Fidelity Management & Research (FMR) | 1.95M | 1.95M | 2.12M | 2.10M | 2.08M | 2.06M | 3.41M | 3.70M | 3.02M | 2.78M |
| Geode Capital Management | 225.05K | 234.94K | 597.16K | 596.18K | 614.52K | 596.02K | 716.29K | 753.52K | 803.65K | 972.63K |
| D. E. Shaw & Co | — | — | 8.78K | — | — | — | — | 233.32K | 368.80K | 872.01K |
| Goldman Sachs Group | — | — | 72.97K | 207.27K | 76.88K | 339.20K | 431.94K | 742.53K | 853.43K | 853.72K |
| Point72 Asset Management | 28.90K | — | — | — | — | — | — | 216.66K | 748.20K | 566.80K |
| Millennium Management | 211.69K | 12.10K | 216.63K | 52.55K | 158.06K | 176.17K | 286.10K | 281.95K | 425.92K | 438.66K |
| UBS Group AG | 9.89K | 11.98K | 18.64K | 72.69K | 202.19K | 86.59K | 497.60K | 450.92K | 486.26K | 438.59K |
| Balyasny Asset Management | — | — | — | — | — | 14.29K | — | 43.03K | 426.28K | 395.45K |
| Northern Trust Corp | 78.41K | 78.19K | 230.51K | 241.01K | 237.70K | 206.75K | 231.17K | 245.60K | 268.81K | 332.75K |
| Charles Schwab Investment Management | 77.76K | 79.73K | 202.37K | 206.38K | 196.49K | 188.20K | 243.49K | 250.59K | 258.77K | 294.22K |
| Citadel Advisors | 286.51K | — | — | — | — | 33.66K | — | 458.50K | 353.26K | 238.34K |
| Morgan Stanley | 21.14K | 41.38K | 167.73K | 148.58K | 121.94K | 101.35K | 392.02K | 97.59K | 128.55K | 189.91K |
| Bank of America Corp | 2.26K | 6.30K | 43.27K | 45.54K | 29.29K | 30.75K | 45.98K | 56.52K | 80.21K | 174.87K |
| BNY Mellon | 22.71K | 29.85K | 68.32K | 68.00K | 68.22K | 58.78K | 63.28K | 73.11K | 75.45K | 103.93K |
| Wellington Management Group | — | — | — | 41.92K | 61.35K | 66.33K | 81.75K | 82.28K | 78.21K | 100.86K |
| JPMorgan Chase & Co | 12.56K | 4.39K | 12.45K | 15.69K | 16.33K | 14.41K | 13.99K | 69.39K | — | 65.69K |
| Two Sigma Investments | — | — | — | — | 41.38K | — | 91.72K | 77.48K | 48.68K | 57.80K |
| Citigroup Inc | 1.74K | 2.16K | 20.40K | 34.12K | 34.17K | 21.57K | 10.04K | 8.09K | 7.43K | 41.27K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details